Literature DB >> 20490721

Hyperbaric oxygen in the management of chronic diabetic foot ulcers.

Andrew J M Boulton1.   

Abstract

Entities:  

Year:  2010        PMID： 20490721     DOI： 10.1007/s11892-010-0121-7

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  9 in total

1.  Point: hyperbaric oxygen is beneficial for diabetic foot wounds.

Authors:  Robert C Barnes
Journal:  Clin Infect Dis       Date:  2006-06-12       Impact factor: 9.079

2.  The right to bear legs--an amendment to healthcare: how preventing amputations can save billions for the US Health-care System.

Authors:  Lee C Rogers; Lawrence A Lavery; David G Armstrong
Journal:  J Am Podiatr Med Assoc       Date:  2008 Mar-Apr

3.  Counterpoint: hyperbaric oxygen for diabetic foot wounds is not effective.

Authors:  A R Berendt
Journal:  Clin Infect Dis       Date:  2006-06-12       Impact factor: 9.079

4.  High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study.

Authors:  L Prompers; M Huijberts; J Apelqvist; E Jude; A Piaggesi; K Bakker; M Edmonds; P Holstein; A Jirkovska; D Mauricio; G Ragnarson Tennvall; H Reike; M Spraul; L Uccioli; V Urbancic; K Van Acker; J van Baal; F van Merode; N Schaper
Journal:  Diabetologia       Date:  2006-11-09       Impact factor: 10.122

5.  Hyperbaric oxygen therapy for diabetic foot wounds: has hope hurdled hype?

Authors:  Benjamin A Lipsky; Anthony R Berendt
Journal:  Diabetes Care       Date:  2010-05       Impact factor: 19.112

Review 6.  Hyperbaric oxygen therapy for chronic wounds.

Authors:  P Kranke; M Bennett; I Roeckl-Wiedmann; S Debus
Journal:  Cochrane Database Syst Rev       Date:  2004

7.  The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial.

Authors:  A Abidia; G Laden; G Kuhan; B F Johnson; A R Wilkinson; P M Renwick; E A Masson; P T McCollum
Journal:  Eur J Vasc Endovasc Surg       Date:  2003-06       Impact factor: 7.069

8.  Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Majid Kalani; Jan Apelqvist; Margareta Blombäck; Kerstin Brismar; Björn Eliasson; Jan W Eriksson; Bengt Fagrell; Anders Hamsten; Ole Torffvit; Gun Jörneskog
Journal:  Diabetes Care       Date:  2003-09       Impact factor: 19.112

Review 9.  The diabetic foot: from art to science. The 18th Camillo Golgi lecture.

Authors:  A J M Boulton
Journal:  Diabetologia       Date:  2004-07-28       Impact factor: 10.122
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.